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Abstract
Background: Adenosine is the first-line pharmacotherapy for termination of supraventricular tachycardia through
its action on the atrioventricular node. However, pro-arrhythmic effects of adenosine are also recognised, most
notably in the presence of pre-excited atrial fibrillation. In this case report, we describe the induction of ventricular
fibrillation in a patient with no demonstrable accessory pathway, nor any other structural heart disease. This rare,
idiosyncratic reaction has never previously been reported and is of relevance given the widespread and routine use
of adenosine in clinical practice.
Case presentation: A 26-year-old woman of Cypriot origin presented to our emergency department with a
sudden onset of palpitations and chest discomfort. She was healthy, with no previous medical history and no
regular medications. An electrocardiogram demonstrated a narrow complex tachycardia with a rate of 194 beats
per minute. Following failure of vagal maneuvers to terminate the tachycardia, the assessing physician
administered a single intravenous dose of 6 mg adenosine. Our patient instantaneously developed coarse
ventricular fibrillation and circulatory collapse. Cardiopulmonary resuscitation was initiated and our patient was
rapidly defibrillated to sinus rhythm with a single 150 J direct current shock. A 900-mg loading dose of
intravenous amiodarone was commenced and our patient was managed in the cardiac high dependency unit.
No further arrhythmias were identified on continuous cardiac monitoring.
On review, her presenting electrocardiogram had demonstrated rapidly conducted atrial fibrillation with no
evidence of ventricular pre-excitation. Concordantly, her resting electrocardiogram was not suggestive of any
accessory pathway. This was conclusively excluded on invasive electrophysiology study, with negative programmed
ventricular stimulation up to three extrastimuli. Extensive laboratory investigations were unremarkable and failed
to identify an underlying cause for her episode of atrial fibrillation. Furthermore, cardiac magnetic resonance
imaging demonstrated a structurally normal heart, with no edema, fibrosis or infarction as well as normal
coronary artery anatomy.
Conclusions: Adenosine remains a safe and highly efficacious therapy for supraventricular tachycardia. However,
this unusual case demonstrates the ability of adenosine to induce circulatory collapse and reminds the clinician
that prompt access to resuscitation, defibrillation, and transcutaneous pacing equipment is mandatory with every
administration of this drug.
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Background
Adenosine is an endogenous nucleoside and the first-line
pharmacological agent for the diagnosis and termination
of supraventricular tachycardia (SVT). The primary
mechanism of action is mediated through inhibition of
the conduction capabilities of the atrioventricular node.
However, pro-arrhythmic effects of adenosine are
increasingly recognised, suggesting a more heterogeneous
pharmacodynamic profile. Recognized tachyarrhythmias
following administration of adenosine include (1) induc-
tion of atrial fibrillation (AF), (2) ventricular fibrillation
(VF) in pre-excited AF, (3) polymorphic ventricular tachy-
cardia (VT) in long Q-T syndromes, (4) degeneration of
VT to VF and finally, (5) non-sustained VT following
termination of SVT [1]. Below, a case of ventricular
fibrillation following administration of adenosine in a
structurally normal heart is described. To the best of our
knowledge, this is a novel finding which has not been
previously reported in the literature.
Case presentation
A 26-year-old woman of Cypriot origin presented with
an acute onset of palpitations and chest tightness. She
reported several weeks’ history of similar palpitations,
however, this was the first occasion that the sensation
had not self-terminated within minutes and had been
associated with discomfort.
There was no further medical history of note, no
relevant family history, and no regular medications. Our
patient admitted to a moderate alcohol intake although
no recent intoxication and no recreational drug use.
On assessment in the Emergency Department, her
electrocardiogram (ECG) demonstrated a narrow-
complex tachycardia with a rate of 194 beats per mi-
nute (bpm) (Fig. 1a). Her heart rate varied between
180 and 210 bpm and her blood pressure was 187/
101 mmHg on first recording. Suspecting SVT, the
assessing emergency physicians proceeded with vagal
maneuvers, to no clinical effect. Next, an intravenous
bolus dose of 6 mg adenosine was administered. This
was followed by immediate development of coarse VF
(Fig. 1b) and circulatory collapse. Rapid deterioration
to a fine VF ensued. She was successfully defibrillated
with a single 150 J direct current shock. There was imme-
diate return of spontaneous circulation and hemodynamic
stability. A 900-mg loading dose of intravenous amioda-
rone was commenced and our patient was admitted to the
cardiac high dependency unit. No further arrhythmias
were identified.
Investigations revealed normal serum electrolytes,
negative serial troponin measurements, normal thyroid
function, and negative blood ethanol level. A urine drug
screen was negative. A chest radiograph demonstrated
clear lung fields. The presenting ECG was reviewed,
and was likely to be that of AF with a rapid ventricular
response, but with no clear ventricular pre-excitation.
Similarly, her ECG in sinus rhythm had no features of
ventricular pre-excitation (Fig. 2a). The Q-Tc interval
was within normal range and there were no features of
Fig. 1 a Twelve-lead electrocardiogram at initial presentation. b Onset of ventricular fibrillation following administration of adenosine
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Brugada syndrome. In view of the development of VF
with adenosine, an electrophysiology study was per-
formed. Following administration of adenosine, there
was progressive PR lengthening and eventual atrioven-
tricular (AV) block with non-conducted P waves, exclud-
ing a typical anterograde conducting accessory pathway
(Fig. 2b). There was also a negative programmed ven-
tricular stimulation up to three extrastimuli. On exercise
stress testing, there was an appropriate heart rate and
blood pressure response with no ST/T wave changes
and no arrhythmias identified. Cardiac magnetic reson-
ance imaging (MRI) confirmed normal biventricular
volumes and systolic function, no myocardial edema,
fibrosis or infarction, and normal origins of the right
and left coronary arteries.
Our patient was discharged, without any prescribed
medications, following a short inpatient stay during
which no further episodes of arrhythmia were identified
on continuous cardiac monitoring. At routine follow-up
3 months later, our patient remained well, with no
further symptoms and no recurrence of palpitations. She
was satisfied by the care she had received and was
discharged from routine outpatient review.
Discussion
The widespread use of adenosine in emergency depart-
ments is testament to a high degree of safety and efficacy
in routine practice. The case described represents a rare,
idiosyncratic response to adenosine with an unclear
mechanism.
a
b
Fig. 2 a Resting electrocardiogram in sinus rhythm. b A four-wire electrophysiology study was conducted in our patient. Twelve milligrams of
adenosine was administered resulting in progressive lengthening of the PR interval (surface electrocardiogram V2), and eventual atrioventricular
block (red arrow) with non-conducted P waves. This excluded the presence of an anterograde conducting accessory pathway. HRA high right
atrium, CS coronary sinus, HIS His and RV right ventricular apex catheters
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Ventricular ectopy and non-sustained monomorphic
and polymorphic VT without hemodynamic compromise
have often been reported following the administration of
adenosine in structurally normal hearts [2, 3]. Further-
more, a case of adenosine-induced ventricular flutter,
degenerating to VF, with concurrent administration of
verapamil and digoxin has been observed as a pause-
dependent phenomenon [4]. However, this is the first
published case report of ventricular fibrillation with
hemodynamic collapse, induced by adenosine in an
otherwise healthy heart. Specifically, this case is novel in
demonstrating adenosine-induced VF in the absence of
bradyarrhythmia, ventricular pre-excitation or use of other
anti-arrhythmic drugs.
DiMarco and colleagues [5] identified ventricular ectopy
in one third of all patients following administration of
adenosine, suggesting a widespread effect of increased
ventricular automaticity. This finding has been supported
in animal studies, whereby the pro-excitatory effects of
adenosine have been isolated to the A2 adenosine receptor
in ventricular myocytes [6]. Catecholamine release is also
a precipitating factor for increased ventricular automati-
city [6], and in fact adenosine has been demonstrated to
activate a cyclic adenosine monophosphate (cAMP)-
dependent system which serves to sensitize the myocar-
dium to the actions of catecholamines, potentiating their
effect [7]. Furthermore, adenosine administration is inde-
pendently associated with a reflex increase in sympathetic
tone and circulating catecholamine levels [8]. These
mechanisms may, at least in part, be responsible for the
development of VF with adenosine, from rapidly con-
ducted AF in the context of an adrenergic state.
An alternative hypothesis may be found by examining
the effect of adenosine on ventricular repolarization.
Adenosine shortens the effective refractory period in
atrial myocytes and predisposes to atrial arrhythmias
such as atrial fibrillation and flutter through increased
spatial dispersion of refractoriness [1]. This phenomenon,
induced by adenosine, has also been demonstrated in
ventricular myocardium and may predispose to ventricu-
lar arrhythmogenesis in a similar manner [9].
In this patient, a low dose of adenosine (6 mg) was
able to induce a malignant ventricular arrhythmia in the
setting of rapidly conducted atrial fibrillation. However,
in sinus rhythm, a greater dose of adenosine (12 mg)
had no such effect. This suggests that atrial fibrillation
with a rapid ventricular response provides an unstable
electrical substrate, likely due to irregular R-R intervals
and variable ventricular refractory periods, that renders
the ventricles susceptible to the pro-arrhythmic effects
of adenosine, as mentioned previously.
Unfortunately, a 12-lead electrocardiogram (ECG) was
not recorded in this patient at the moment of adminis-
tration of adenosine. Recording a continuous 12-lead
ECG during therapeutic interventions such as adminis-
tration of anti-arrhythmic drugs should be encouraged,
as in this case, it may have shed valuable light on the
underlying mechanism for arrhythmia which could not
be appreciated from a rhythm strip alone.
Conclusions
Clinically, this unusual case serves as a reminder of the
ability of adenosine to induce ventricular tachyarrhyth-
mias associated with circulatory collapse. The well-
recognised adverse effects of bronchospasm, chest pain
and bradycardia, combined with the potential for ven-
tricular arrhythmias should mandate all physicians to use
adenosine only where there is prompt access to resuscita-
tion, defibrillation, and transcutaneous pacing equipment.
Nevertheless, physicians should not be deterred from
using this highly efficacious agent where an appropriate
assessment of the risks incurred has been borne in mind.
Abbreviations
AF: atrial fibrillation; ECG: electrocardiogram; MRI: magnetic resonance
imaging; SVT: supraventricular tachycardia; VF: ventricular fibrillation;
VT: ventricular tachycardia
Acknowledgements
None.
Funding
FSN is supported by a National Institute of Health Research Clinical
Lectureship (1716). The electrophysiology group at Imperial College
London is supported by the National Institute of Health Research
Biomedical Research Scheme.
Availability of data and materials
All data generated or analyzed during this study are included in this
published article.
Authors’ contributions
CAR and NQ were major contributors in the writing and preparation of the
manuscript. VFP was involved in critically reviewing the manuscript for
intellectual content. FSN and PBL were involved in the acquisition and
interpretation of data. All authors read and approved the manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient for publication of
this case report and any accompanying images. A copy of the written
consent is available for review by the Editor-in-Chief of this journal.
Ethics approval and consent to participate
Not applicable.
Received: 3 September 2016 Accepted: 12 December 2016
References
1. Mallet ML. Proarrhythmic effects of adenosine: a review of the literature.
Emerg Med J. 2004;21:408–10.
2. Tan HL, Spekhorst HH, Peters RJ, Wilde AA. Adenosine induced ventricular
arrhythmias in the emergency room. Pacing Clin Electrophysiol. 2001;24:450–5.
3. Smith JR, Goldberger JJ, Kadish AH. Adenosine induced polymorphic
ventricular tachycardia in adults without structural heart disease. Pacing Clin
Electrophysiol. 1997;20:743–5.
Rajkumar et al. Journal of Medical Case Reports  (2017) 11:21 Page 4 of 5
4. Ben-Sorek ES, Wiesel J. Ventricular fibrillation following adenosine
administration. A case report. Arch Intern Med. 1993;153:2701–2.
5. DiMarco JP, Miles W, Akhtar M, Milstein S, Sharma AD, Platia E, McGovern B,
Scheinman MM, Govier WC. Adenosine for paroxysmal supraventricular
tachycardia: dose ranging and comparison with verapamil. Assessment in
placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.
Ann Intern Med. 1990;113:104–10.
6. Hernandez J, Ribeiro JA. Excitatory actions of adenosine on ventricular
automaticity. Trends Pharmacol Sci. 1996;17:141–4.
7. Hernandez J, Laorden ML, Ruiz F, Ribeiro JA. Effects of adenosine and
its analogues on ventricular automaticity induced by a local injury:
role of catecholamines and of cyclic AMP. Arch Int Pharmacodyn Ther.
1989;297:49–59.
8. Biaggioni I, Olafsson B, Robertson RM, Hollister AS, Robertson D.
Cardiovascular and respiratory effects of adenosine in conscious man.
Evidence for chemoreceptor activation. Circ Res. 1987;61:779–86.
9. Kumar A, Narasimhan C, Sankari A, Ranginani A, Lennon C, Bekerman C,
Clark W, Denes P. Changes in QT dispersion during adenosine infusion.
Clin Cardiol. 2000;23:760–2.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Rajkumar et al. Journal of Medical Case Reports  (2017) 11:21 Page 5 of 5
